469
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Ambulatory Blood Pressure Monitoring: Killing the Elephant to Get Its Hair? No More, Please!

, &
Pages 1-5 | Received 20 Jul 2012, Accepted 13 Aug 2012, Published online: 24 Sep 2012

REFERENCES

  • Akerstedt T, Nordin M, Alfredsson L, Westerholm P, Kecklund G. (2010). Sleep and sleepiness: impact of entering or leaving shiftwork–a prospective study. Chronobiol. Int. 27:987–996.
  • Armstrong RG, Kenny GP, Green G, Seely AJ. (2011). Diurnal variation in heart rate variability before and after maximal exercise testing. Chronobiol. Int. 28:344–351.
  • Auger RR, Burgess HJ, Dierkhising RA, Sharma RG, Slocumb NL. (2011). Light exposure among adolescents with delayed sleep phase disorder: a prospective cohort study. Chronobiol. Int. 28:911–920.
  • Ayala DE, Hermida RC. (2013). Ambulatory blood pressure monitoring for the early identificaton of hypertension in pregnancy. Chronobiol. Int. 30:233–259.
  • Ayala DE, Hygia Project Investigators, Hermida RC, Portaluppi F, Smolensky MH. (2011). Bedtime hypertension treatment increases ambulatory blood pressure control and reduces cardiovascular risk in resistant hypertension. Hypertension 58:e26.
  • Ayala DE, Hermida RC, Mojón A, Fernández JR. (2013a). Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications. Chronobiol. Int. 30:340–352.
  • Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, Sineiro E, Mojón A, Fontao MJ, Hermida RC, on behalf of the Hygia Project Investigators. (2013b). Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol. Int. 30:99–115.
  • Ayala DE, Ucieda R, Hermida RC. (2013c). Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol. Int. 30:260–279.
  • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ, and the National High Blood Pressure Education Coordinating Committee. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 289:2560–2571.
  • Corbalan-Tutau MD, Madrid JA, Ordovas JM, Smith CE, Nicolas F, Garaulet M. (2011). Differences in daily rhythms of wrist temperature between obese and normal-weight women: associations with metabolic syndrome features. Chronobiol. Int. 28:425–433.
  • Coste O, Chaumet G, Van Beers P, Touitou Y. (2011). Hypobaric impact on clinical tolerance and 24-h patterns in iron metabolism markers and plasma proteins in men. Chronobiol. Int. 28:434–445.
  • Crespo C, Fernández JR, Aboy M, Mojón A. (2013). Clinical application of a novel automatic algorithm for actigraphy-based activity and rest period identification to accurately determine awake and asleep ambulatory blood pressure parameters and cardiovascular risk. Chronobiol. Int. 30:43–54.
  • Crespo JJ, Piñeiro L, Otero A, Castiñeira C, Ríos MT, Regueiro A, Mojón A, Lorenzo S, Ayala DE, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Chronobiol. Int. 30:159–175.
  • Driesen K, Jansen NW, Kant I, Mohren DC, van Amelsvoort LG. (2010). Depressed mood in the working population: associations with work schedules and working hours. Chronobiol. Int. 27:1062–1079.
  • Fabbian F, Smolensky MH, Tiseo R, Pala M, Manfredini R, Portaluppi F. (2013). Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms. Chronobiol. Int. 30:17–30.
  • Gallerani M, Portaluppi F, Grandi E, Manfredini R. (1997). Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta. J. Thorac. Cardiovasc. Surg. 113:603–604.
  • Gompper B, Bromundt V, Orgul S, Flammer J, Krauchi K. (2010). Phase relationship between skin temperature and sleep-wake rhythms in women with vascular dysregulation and controls under real-life conditions. Chronobiol. Int. 27:1778–1796.
  • Grimaldi D, Agati P, Pierangeli G, Franceschini C, Guaraldi P, Barletta G, Vandi S, Cevoli S, Plazzi G, Montagna P, Cortelli P. (2010). Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation. Chronobiol. Int. 27:1596–1608.
  • Grimaldi D, Provini F, Calandra-Buonaura G, Barletta G, Cecere A, Pierangeli G, Cortelli P. (2013). Cardiovascular-sleep interaction in drug-naive patients with essential grade 1 hypertension. Chronobiol. Int. 30:31–42.
  • Hammouda O, Chtourou H, Chahed H, Ferchichi S, Kallel C, Miled A, Chamari K, Souissi N. (2011). Diurnal variations of plasma homocysteine, total antioxidant status, and biological markers of muscle injury during repeated sprint: effect on performance and muscle fatigue–a pilot study. Chronobiol. Int. 28:958–967.
  • Hermida RC, Ayala DE, Mojon A, Fernandez JR. (2010). Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol. Int. 27:1629–1651.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011a). Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care 34:1270–1276.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011b). Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J. Am. Coll. Cardiol. 58:1165–1173.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2011c). Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22:2313–2321.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012a). Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am. J. Hypertens. 25:297–305.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2012b). Sleep-time blood pressure as a therapeutic target for cardiovascular risk reduction in type 2 diabetes. Am. J. Hypertens. 25:325–334.
  • Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR. (2013a). Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol. Int. 30:176–191.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A. (2013b). Sleep-time blood pressure: Prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol. Int. 30:68–86.
  • Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. (2013c). Administration-time-differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol. Int. 30:280–314.
  • Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. (2013d). Ambulatory blood pressure monitoring: Importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol. Int. 30:55–67.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013e). Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level – The “normotensive non-dipper” paradox. Chronobiol. Int. 30:87–98.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013f). Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes. Chronobiol. Int. 30:132–144.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013g). Cardiovascular risk of essential hypertension: Influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol. Int. 30:315–327.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR. (2013h). Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk. Chronobiol. Int. 30:328–339.
  • Hermida RC, Ayala DE, Mojón A, Fontao MJ, Chayán L, Fernández JR. (2013i). Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol. Int. 30:221–232.
  • Hermida RC, Ríos MT, Crespo JJ, Moya A, Domínguez-Sardiña M, Otero A, Sánchez JJ, Mojón A, Fernández JR, Ayala DE, on behalf on the Hygia Project Investigators. (2013j). Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension. Chronobiol. Int. 30:192–206.
  • Innominato PF, Giacchetti S, Moreau T, Smaaland R, Focan C, Bjarnason GA, Garufi C, Iacobelli S, Tampellini M, Tumolo S, Carvalho C, Karaboue A, Levi F. (2011). Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). Chronobiol. Int. 28:586–600.
  • Kershenbaum A, Kershenbaum A, Tarabeia J, Stein N, Lavi I, Rennert G. (2011). Unraveling seasonality in population averages: an examination of seasonal variation in glucose levels in diabetes patients using a large population-based data set. Chronobiol. Int. 28:352–360.
  • Kishi T, Yoshimura R, Fukuo Y, Kitajima T, Okochi T, Matsunaga S, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Umene-Nakano W, Nakamura J, Ozaki N, Serretti A, Correll CU, Iwata N. (2011). The CLOCK gene and mood disorders: a case-control study and meta-analysis. Chronobiol. Int. 28:825–833.
  • Lin HC, Chen CS, Keller JJ, Ho JD, Lin CC, Hu CC. (2011). Seasonality of retinal detachment incidence and its associations with climate: an 11-year nationwide population-based study. Chronobiol. Int. 28:942–948.
  • Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker HAJ, Zanchetti A. (2007). 2007 guidelines for the management of arterial hypertension.The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25:1105–1187.
  • Manfredini R, Gallerani M, Portaluppi F, Fersini C. (1996). Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:141–158.
  • Manfredini R, Boari B, Salmi R, Fabbian F, Pala M, Tiseo R, Portaluppi F. (2013). 24-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol. Int. 30:6–16.
  • Mazzoccoli G, Panza A, Valvano MR, Palumbo O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P, Andriulli A, Piepoli A. (2011). Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol. Int. 28:841–851.
  • Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, Pérez de Lis J, Fernández JR, Hermida RC, on behalf of the Hygia Project Investigators. (2013). Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol. Int. 30:145–158.
  • Morris CJ, Fullick S, Gregson W, Clarke N, Doran D, MacLaren D, Atkinson G. (2010). Paradoxical post-exercise responses of acylated ghrelin and leptin during a simulated night shift. Chronobiol. Int. 27:590–605.
  • Moyá A, Crespo JJ, Ayala DE, Ríos MT, Pousa L, Callejas PA, Salgado JL, Mojón A, Fernández JR, Hermida RC, on behalf on the Hygia Project Investigators. (2013). Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes. Chronobiol. Int. 30:116–131.
  • National Institute for Health and Clinical Excellence. (2011). Hypertension: The clinical management of primary hypertension in adults. Clinical Guideline: Methods, evidence and recommendations. http://guidance.nice.org.uk/CG/Wave2/14.
  • Palma-Rigo K, Baudrie V, Laude D, Petrel C, Clauser E, Elghozi JL. (2010). Cardiovascular rhythms and cardiac baroreflex sensitivity in AT(1A) receptor gain-of-function mutant mice. Chronobiol. Int. 27:128–137.
  • Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. (2005). Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. Hypertension. 45:142–161.
  • Pinotti M, Bertolucci C, Portaluppi F, Colognesi I, Frigato E, Foa A, Bernardi F. (2005). Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity. Arterioscler. Thromb. Vasc. Biol. 25:646–649.
  • Portaluppi F, Smolensky MH. (2010). Perspectives on the chronotherapy of hypertension based on the results of the MAPEC study. Chronobiol. Int. 27:1652–1667.
  • Portaluppi F, Montanari L, Ferlini M, Gilli P. (1990). Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol. Int. 7:321–327.
  • Portaluppi F, Trasforini G, Margutti A, Vergnani L, Ambrosio MR, Rossi R, Bagni B, Pansini R, degli Uberti EC. (1992). Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J. Hypertens. 10:1227–1234.
  • Portaluppi F, Cortelli P, Avoni P, Vergnani L, Contin E, Maltoni P, Pavani A, Sforza E, degli Uberti EC, Gambetti P, Lugaresi E. (1994). Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia. Hypertension 23:569–576.
  • Portaluppi F, Vergnani L, Manfredini R, Fersini C. (1996). Endocrine mechanisms of blood pressure rhythms. Ann. N. Y. Acad. Sci. 783:113–131.
  • Portaluppi F, Boari B, Manfredini R. (2004). Oxidative stress in essential hypertension. Curr. Pharm. Des. 10:1695–1698.
  • Portaluppi F, Fabbian F, Manfredini F, Manfredini R. (2011). Lack of time-of-day differences is not necessarily indicative of lack of circadian influences. Chronobiol. Int. 28:731–733.
  • Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. (2012). Circadian rhythms and cardiovascular health. Sleep Med. Rev. 16:151–166.
  • Racinais S, Perrey S, Denis R, Bishop D. (2010). Maximal power, but not fatigability, is greater during repeated sprints performed in the afternoon. Chronobiol. Int. 27:855–864.
  • Riedel M, Berrez S, Pelisse D, Brousse E, Forget C, Marlot M, Smolensky MH, Touitou Y, Reinberg A. (2011). 24-hour pattern of work-related injury risk of French firemen: nocturnal peak time. Chronobiol. Int. 28:697–705.
  • Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, on behalf of the Hygia project Investigators. (2013). Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Chronobiol. Int. 30:207–220.
  • Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, Hua TA, Weber MA, Jamerson K, for the VALUE Investigators (2007). Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J. Hypertens. 25:1473–1479.
  • Smolensky MH, Hermida RC, Castriotta RJ, Portaluppi F. (2007). Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 8:668–680.
  • Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. (2010). Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press. Monit. 15:173–180.
  • Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. (2012). Biological rhythms, drug delivery, and chronotherapeutics. In Siepmann J, Siegel RA, Rathbone MJ (eds). Fundamentals and Applications of Controlled Release Drug Delivery. Heidelberg Germany: Springer Verlag, pp. 359–443.
  • Trasforini G, Margutti A, Portaluppi F, Menegatti M, Ambrosio MR, Bagni B, Pansini R, Degli Uberti EC. (1991). Circadian profile of plasma calcitonin gene-related peptide in healthy man. J. Clin. Endocrinol. Metab. 73:945–951.
  • To H, Yoshimatsu H, Tomonari M, Ida H, Tsurumoto T, Tsuji Y, Sonemoto E, Shimasaki N, Koyanagi S, Sasaki H, Ieiri I, Higuchi S, Kawakami A, Ueki Y, Eguchi K. (2011). Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol. Int. 28:267–274.
  • Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. (1999). Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation 99:2499–2502.
  • Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, Borea PA. (2000). Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects. Circulation 102:285–289.
  • Verdecchia P, Angeli F, Mazzotta G, Garofoli M, Ramundo E, Gentile G, Ambrosio G, Reboldi G. (2012). Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 60:34–42.
  • Vieira WS, Hidalgo MP, Torres Ida S, Caumo W. (2010). Biological rhythms of spinal-epidural labor analgesia. Chronobiol. Int. 27:865–878.
  • White WB. (2012). “The nighttime might be the right time” for cardiovascular event prediction. Hypertension 60:8–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.